Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07281976
What this trial is testing

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Nanjing Leads Biolabs Co.,Ltd 220
Not applicableActive Not RecruitingNCT07484776
What this trial is testing

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Universidad Europea de Madrid 40
Testing effectiveness (Phase 2)Study completedNCT03164993
What this trial is testing

Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer

Who this might be right for
Cancer, BreastTriple Negative Breast Cancer
Oslo University Hospital 68
Early research (Phase 1)Study completedNCT03800836
What this trial is testing

Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 139
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07271992
What this trial is testing

TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer

Who this might be right for
TNBC, Triple Negative Breast Cancer
First Hospital of China Medical University 30
Testing effectiveness (Phase 2)Ended earlyNCT04461600
What this trial is testing

AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Ayala Pharmaceuticals, Inc, 18
Large-scale testing (Phase 3)Study completedNCT02546934
What this trial is testing

ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Fudan University 254
Early research (Phase 1)Active Not RecruitingNCT05081492
What this trial is testing

CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8
City of Hope Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT04320030
What this trial is testing

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers

Who this might be right for
Triple Negative Breast Cancer
Institut Cancerologie de l'Ouest 13
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Not applicableNot Yet RecruitingNCT06975644
What this trial is testing

Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Neoadjuvant ChemotherapyChemotherapy Effects
Zhejiang Provincial People's Hospital 55
Testing effectiveness (Phase 2)UnknownNCT03775928
What this trial is testing

Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 80
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Testing effectiveness (Phase 2)UnknownNCT05928780
What this trial is testing

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 125
Testing effectiveness (Phase 2)Study completedNCT03205761
What this trial is testing

Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Spanish Breast Cancer Research Group 11
Early research (Phase 1)UnknownNCT05957939
What this trial is testing

Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Ministry of Health, Saudi Arabia 2
Testing effectiveness (Phase 2)Ended earlyNCT02457910
What this trial is testing

Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more
Vanderbilt-Ingram Cancer Center 30
Early research (Phase 1)Study completedNCT02996825
What this trial is testing

Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+3 more
City of Hope Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT02657889
What this trial is testing

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

Who this might be right for
NeoplasmsTriple Negative Breast CancerOvarian Cancer+6 more
Tesaro, Inc. 122
Testing effectiveness (Phase 2)Looking for participantsNCT04333706
What this trial is testing

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

Who this might be right for
BreastMetastaticTriple Negative+2 more
University of Southern California 65
Next Page